Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Spondyloarthritis (Proof-of-Concept, Double-Blind, Placebo-Controlled, Randomized Phase 2 Trial)
2010-023185-42Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in spondyloarthritis (SpA) comparing Nilotinib with Placebo (2 arms). Primary endpoint: Patient global assessment of disease activity VAS at week 12. Started Nov 2010; status: completed.
02
Drugs
nilotinib
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on 2010-023185-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023185-42.